PureTech Health plc (NASDAQ:PRTC) Short Interest Up 77.7% in December

PureTech Health plc (NASDAQ:PRTC) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 35,900 shares, a growth of 77.7% from the December 15th total of 20,200 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is currently 8.0 days.

PureTech Health Stock Performance

PRTC opened at $17.88 on Wednesday. The stock’s fifty day moving average is $20.71 and its two-hundred day moving average is $21.16. PureTech Health has a 52 week low of $17.00 and a 52 week high of $34.00.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.